| Autor: |
Ryu Tiger YK; Division of Hematology and Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., Jain S; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute, Cambridge, MA, USA., Barta SK; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Department of Hematology and Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Tolu S; Division of Hematology and Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., Estrella B; Division of Hematology and Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., Sawas A; Division of Hematology and Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., Lue JK; Division of Hematology and Oncology, Memorial Sloan Kettering, New York, NY, USA., Francescone MM; Department of Radiology, Columbia University Irving Medical Center, New York, NY, USA., Pro B; Division of Hematology and Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., Amengual JE; Division of Hematology and Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA. |
